Tourniquet (junctional): Difference between revisions
No edit summary |
No edit summary |
||
| (5 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
[[File:Sobo 1909 573-574.png|thumb|Anterior thigh anatomy (right) showing vein medial to artery and nerve.]] | |||
*Junctional tourniquets are devices that allow for proximal compression of arterial bleeding and thus control of junctional hemorrhage | *Junctional tourniquets are devices that allow for proximal compression of arterial bleeding and thus control of junctional hemorrhage | ||
*Junctional tourniquets (JTQ) were initially cleared by FDA in 2010 for use in pre-hospital medicine | *Junctional tourniquets (JTQ) were initially cleared by FDA in 2010 for use in pre-hospital medicine | ||
| Line 6: | Line 7: | ||
==Properties of a good junctional tourniquet== | ==Properties of a good junctional tourniquet== | ||
[[File:PMC5022193 13049 2016 301 Fig2 HTML.png|thumb|iTClamp™.]] | |||
[[File:PMC5022193 13049 2016 301 Fig5 HTML.png|thumb|SAM-JT™.]] | |||
[[File:PMC5022193 13049 2016 301 Fig4 HTML.png|thumb|JETT™.]] | |||
[[File:PMC5022193 13049 2016 301 Fig3 HTML.png|thumb|AAJT™.]] | |||
*Stop bleeding effectively from junction areas such as groin, pelvis, shoulder, or neck | *Stop bleeding effectively from junction areas such as groin, pelvis, shoulder, or neck | ||
*Compress bleeding from sites where regular TQ cannot be applied | *Compress bleeding from sites where regular TQ cannot be applied | ||
| Line 38: | Line 43: | ||
*[[Resuscitative endovascular balloon occlusion of the aorta]] | *[[Resuscitative endovascular balloon occlusion of the aorta]] | ||
*[[Tourniquet]] | *[[Tourniquet]] | ||
==External Links== | |||
===Videos=== | |||
{{#widget:YouTube|id=1iP0IbO9Gog}} | |||
==References== | ==References== | ||
Latest revision as of 21:58, 29 June 2021
Background
- Junctional tourniquets are devices that allow for proximal compression of arterial bleeding and thus control of junctional hemorrhage
- Junctional tourniquets (JTQ) were initially cleared by FDA in 2010 for use in pre-hospital medicine
- Developed because of limitations of traditional extremity tourniquets in controlling hemorrhage between the trunk and limbs. These difficult to access locations were responsible for 20% of preventable deaths by bleeding on the battlefield.
- Testing has shown JTQ to be 75-100% effect in controlling hemorrhage
Properties of a good junctional tourniquet
- Stop bleeding effectively from junction areas such as groin, pelvis, shoulder, or neck
- Compress bleeding from sites where regular TQ cannot be applied
- Safe to use
- Effective for prehospital use
- Small with low profile
- Lightweight
- Low-cost
- Easy to use requiring minimal training
- Applied quickly
- Does not slip on tightening when in use
- Provides easy release of compression
- Easy to reapply
- Long shelf life
Indications
- Junctional hemorrhage not controlled by other means
Contraindications
- None
Application of Junctional Tourniquet
- Application varies by tourniquet design (multiple different types of junctional tourniquet exist)
- Clearly mark tourniquet with time of application
Proper removal in hospital setting
- Loosen the tourniquet while observing wound for bleeding
- If wound now hemostatic, leave pressure off
- If wound continues to bleed, re-apply pressure and prepare for urgent definitive management of bleeding
See Also
External Links
Videos
{{#widget:YouTube|id=1iP0IbO9Gog}}